Method and device producing a predetermined distribution of dete

Chemistry: analytical and immunological testing – Involving iga – igd – ige – or igm

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

436169, 435 11, G01N 33563

Patent

active

059688394

ABSTRACT:
A transport matrix and diagnostic device are provided which produce a physically detectable change in a predetermined distribution across a detection zone which correlates with the amount of selected analyte in a sample. The matrix includes a detection zone having a capture reagent yielding a physically detectable change which correlates with the amount of selected analyte in the sample. The detection zone has a leading boundary which first encounters the sample and a trailing boundary which encounters the sample after being transported across the detection zone. The capture reagent is immobilized on the matrix in a predetermined distribution from the leading boundary to the trailing boundary of the detection zone. A method is also provided which determines the level of a selected analyte in a sample by distributing a physically detectable change in a predetermined pattern across a detection zone on a transport matrix which correlates with the amount of selected analyte.

REFERENCES:
patent: 4038485 (1977-07-01), Johnston et al.
patent: 4094647 (1978-06-01), Deutsch et al.
patent: 4160008 (1979-07-01), Fenocketti et al.
patent: 4168146 (1979-09-01), Grubb et al.
patent: 4224439 (1980-09-01), Ayers et al.
patent: 4233402 (1980-11-01), Maggio et al.
patent: 4235601 (1980-11-01), Deutsch et al.
patent: 4275149 (1981-06-01), Litman et al.
patent: 4281061 (1981-07-01), Zuk et al.
patent: 4313734 (1982-02-01), Leuvering
patent: 4361537 (1982-11-01), Deutsch et al.
patent: 4366241 (1982-12-01), Tom et al.
patent: 4373932 (1983-02-01), Gribnau
patent: 4376110 (1983-03-01), David et al.
patent: 4435504 (1984-03-01), Zuk et al.
patent: 4446232 (1984-05-01), Liotta
patent: 4452901 (1984-06-01), Gordon et al.
patent: 4517288 (1985-05-01), Giegel et al.
patent: 4552839 (1985-11-01), Gould et al.
patent: 4627445 (1986-12-01), Garcia et al.
patent: 4637403 (1987-01-01), Garcia et al.
patent: 4703017 (1987-10-01), Campbell et al.
patent: 4734360 (1988-03-01), Phillips
patent: 4740468 (1988-04-01), Weng et al.
patent: 4756828 (1988-07-01), Litman et al.
patent: 4756884 (1988-07-01), Hillman et al.
patent: 4757004 (1988-07-01), Houts et al.
patent: 4774192 (1988-09-01), Terminiello
patent: 4787398 (1988-11-01), Garcia et al.
patent: 4855240 (1989-08-01), Rosenstein et al.
patent: 4861711 (1989-08-01), Friesen
patent: 4868108 (1989-09-01), Bahar et al
patent: 4883688 (1989-11-01), Houts et al.
patent: 4945205 (1990-07-01), Litman et al.
patent: 4956302 (1990-09-01), Gordon et al.
patent: 4999287 (1991-03-01), Allen et al.
patent: 5026653 (1991-06-01), Lee et al.
patent: 5030558 (1991-07-01), Litman et al.
patent: 5036000 (1991-07-01), Palmer
patent: 5075078 (1991-12-01), Osikowicz et al.
patent: 5087556 (1992-02-01), Ertinghausen
patent: 5096837 (1992-03-01), Fan et al.
patent: 5114350 (1992-05-01), Hewett
patent: 5132086 (1992-07-01), Allen et al.
patent: 5132806 (1992-07-01), Allen et al.
patent: 5155025 (1992-10-01), Allen et al.
patent: 5160486 (1992-11-01), Schapfenbacher et al.
patent: 5171688 (1992-12-01), Hewett et al.
patent: 5202268 (1993-04-01), Kuhn et al.
patent: 5212060 (1993-05-01), Maddox
patent: 5213965 (1993-05-01), Jones
patent: 5223219 (1993-06-01), Subramanian et al.
patent: 5223220 (1993-06-01), Fan et al.
patent: 5234813 (1993-08-01), McGeehan et al.
patent: 5340539 (1994-08-01), Allen et al.
patent: 5354692 (1994-10-01), Yang et al.
patent: 5356785 (1994-10-01), McMahon et al.
patent: 5416000 (1995-05-01), Allen et al.
patent: 5424193 (1995-06-01), Pronovost et al.
patent: 5426030 (1995-06-01), Rittersdorf et al.
patent: 5451504 (1995-09-01), Fitzpatrick
patent: 5580794 (1996-12-01), Allen
patent: 5602040 (1997-02-01), May
A Dot-Immunobinding Assay for Monoclonal and Other Antibodies, Richard Hawkes, Evelyn Niday, and Julian Gordon, Analytical Biochemistry 119, pp. 142-147 (1982).
Detection of Specific Hybridoma Clones by Replica Immunoadsorption of Their Secreted Antibodies, Jacqueline Sharon, Sherie L. Morrison, and Elvin A. Kabat, Dec. 7, 1978, Proc. Natl. Acad. Sci. USA vol. 76, No. 3, pp. 1420-1424 Mar. 1979.
Home Cholesterol Testing, Editorial, The Lancet, vol. 340, Dec. 5, 1992 No. 8832, p. 1386.
Reliability and Feasibility of Pregnancy Home-Use Tests: Laboratory Validation and Diagnostic Evaluation by 638 Volunteers, Joelle Daviaud, Dominique Fournet, Chantal Ballongue, Guy-Pierre Guillem, Alain Leblanc, Claude Casellas, and Bernard Pau, Clin. Chem. 39/1, 53-59 (1993).
A Multilayaer Membrane System for Blood Plasma Isolation for Use in Primary Health Care, APM Van Oudheusden and HDW Roesink, Ann Clin Biochem 1991; 28: 55-59.
Instrument-Free Quantitative Test Systems, Michael P. Allen and Prithipal Singh, Applications of Diagnostics, pp. 147-176 (1990).
Zourlas, PA et al, Clin. Exp. Obstet Gynocol, 1992, vol. 19(3), pp. 180-188 .

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method and device producing a predetermined distribution of dete does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method and device producing a predetermined distribution of dete, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and device producing a predetermined distribution of dete will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2055007

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.